Vol. 4 No. 3 (2026): Top 10 Take-Home Messages of the 2026 CKM Guideline From staging and PREVENT risk to guideline-directed therapy across the spectrum
Description
This newsletter summarises the "Top Things to Know" companion to the 2026 CKM Guideline into a practical, clinic-ready brief. It highlights the guideline’s ten actionable messages that map onto a care workflow—stage, predict (PREVENT), assess, coordinate, and treat—covering CKM staging across ages, long‑horizon risk estimation, systematic metabolic and kidney evaluation, social‑determinants screening, interdisciplinary coordination, obesity reframing and treatments, and organ‑protective pharmacotherapy for type 2 diabetes, CKD, ASCVD, and heart failure. The piece explains how these messages convert directly into order sets, dashboards, and quality metrics to close the gap between publication and bedside implementation.

